Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2550Triple Negative Breast Neoplasms 435Carcinoma, Non-Small-Cell Lung 338Ovarian Neoplasms 315Neoplasms 280Neoplasm Metastasis 253Colorectal Neoplasms 245Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 84Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Breast Carcinoma × Breast × Clear all
NCT02270372 2018-05-17

Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer

Seagen Inc.

Phase 1 Completed
22 enrolled
BreastGynecologic

Advanced Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡